bromopyruvate has been researched along with cytarabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, SP; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Tran, DH; Watanabe, H; Yorita, K | 1 |
1 other study(ies) available for bromopyruvate and cytarabine
Article | Year |
---|---|
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Cisplatin; Citric Acid; Cytarabine; D-Amino-Acid Oxidase; Drug Resistance, Neoplasm; Energy Metabolism; Enzyme Inhibitors; Glioblastoma; Hexokinase; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mice; Neovascularization, Pathologic; Oxidative Stress; Pyruvates | 2012 |